UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BMY — Bristol Myers Squibb Co
CIK 861177
NEW YORK, NY
Position in BMY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,377,926,752
+$221,583,370 QoQ
Shares Held
22,719,320
+6.0% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 49.42765452487134.ToString("F0")%
Shared 0.ToString("F0")%
None 50.57234547512866.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. BMY ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,377,926,752 | 22,719,320 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,156,343,382 | 21,437,586 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $982,681,458 | 21,788,946 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,166,949,135 | 25,209,530 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,379,962,416 | 22,626,044 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,259,689,721 | 22,271,742 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $986,931,335 | 19,074,823 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $667,486,973 | 16,072,405 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $661,339,292 | 12,195,082 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $589,983,000 | 11,498,402 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $643,237,757 | 11,082,663 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $714,331,406 | 11,170,155 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $774,203,435 | 11,170,155 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $784,418,968 | 10,902,279 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $727,005,218 | 10,226,547 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $774,415,026 | 10,057,338 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $701,221,856 | 9,601,833 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $583,842,961 | 9,363,961 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $534,367,578 | 9,031,056 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $611,771,039 | 9,155,508 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $597,812,182 | 9,469,542 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $587,148,929 | 9,465,564 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $520,177,171 | 8,627,918 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $491,596,103 | 8,360,478 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $552,425,700 | 9,910,759 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||